tiprankstipranks
Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
PremiumPress ReleasesElutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
18d ago
Elutia Announces $13.26 Million Registered Direct Offering
PremiumPress Releases
Elutia Announces $13.26 Million Registered Direct Offering
18d ago
Elutia price target lowered to $5 from $6 at Cantor Fitzgerald
PremiumThe Fly
Elutia price target lowered to $5 from $6 at Cantor Fitzgerald
2M ago
New Innovation / R&D Risk for Aziyo Biologics, Inc. Class A – What’s the Latest?
PremiumCompany AnnouncementsNew Innovation / R&D Risk for Aziyo Biologics, Inc. Class A – What’s the Latest?
4M ago
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
PremiumPress Releases
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
4M ago
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
PremiumPress Releases
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
4M ago
Elutia participates in a conference call with Cantor Fitzgerald
PremiumThe FlyElutia participates in a conference call with Cantor Fitzgerald
5M ago
Elutia management to meet with Lake Street
PremiumThe Fly
Elutia management to meet with Lake Street
5M ago
Aziyo Biologics Approves Employee Stock Option Repricing Program
PremiumCompany Announcements
Aziyo Biologics Approves Employee Stock Option Repricing Program
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100